Raymond James Financial Inc. purchased a new position in Delek US Holdings, Inc. (NYSE:DK - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 275,702 shares of the oil and gas company's stock, valued at approximately $5,100,000. Raymond James Financial Inc. owned 0.44% of Delek US at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of DK. Barclays PLC increased its stake in Delek US by 51.5% in the 3rd quarter. Barclays PLC now owns 1,496,825 shares of the oil and gas company's stock worth $28,065,000 after buying an additional 508,719 shares during the period. Geode Capital Management LLC grew its holdings in shares of Delek US by 4.5% during the third quarter. Geode Capital Management LLC now owns 1,459,301 shares of the oil and gas company's stock valued at $27,368,000 after buying an additional 63,502 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Delek US by 76.8% in the third quarter. JPMorgan Chase & Co. now owns 482,169 shares of the oil and gas company's stock valued at $9,041,000 after purchasing an additional 209,474 shares during the last quarter. Wedge Capital Management L L P NC boosted its holdings in Delek US by 8.5% in the fourth quarter. Wedge Capital Management L L P NC now owns 31,856 shares of the oil and gas company's stock valued at $589,000 after purchasing an additional 2,493 shares during the last quarter. Finally, ARS Investment Partners LLC purchased a new stake in Delek US in the fourth quarter valued at $185,000. 97.01% of the stock is currently owned by institutional investors.
Delek US Price Performance
Shares of Delek US stock traded up $0.60 during trading on Thursday, reaching $13.62. The company's stock had a trading volume of 334,864 shares, compared to its average volume of 1,228,420. The stock has a 50-day moving average price of $14.33 and a two-hundred day moving average price of $16.76. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 3.18. Delek US Holdings, Inc. has a one year low of $11.03 and a one year high of $29.14. The stock has a market capitalization of $851.36 million, a P/E ratio of -2.80 and a beta of 1.04.
Delek US (NYSE:DK - Get Free Report) last posted its earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.53) by ($1.01). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The company had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.58 billion. During the same quarter in the previous year, the firm posted ($1.46) earnings per share. Delek US's quarterly revenue was down 39.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Delek US Holdings, Inc. will post -5.5 EPS for the current fiscal year.
Delek US Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, May 19th. Stockholders of record on Monday, May 12th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 7.49%. The ex-dividend date of this dividend is Monday, May 12th. Delek US's dividend payout ratio is currently -11.54%.
Analysts Set New Price Targets
Several research firms recently weighed in on DK. Morgan Stanley reduced their price target on shares of Delek US from $18.00 to $14.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Wolfe Research upgraded Delek US from an "underperform" rating to a "peer perform" rating in a report on Friday, January 3rd. The Goldman Sachs Group decreased their target price on Delek US from $17.00 to $15.00 and set a "neutral" rating for the company in a research report on Wednesday. Mizuho dropped their price objective on shares of Delek US from $25.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 9th. Finally, Piper Sandler lowered their price target on shares of Delek US from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Five equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $16.94.
Get Our Latest Stock Report on DK
Insider Transactions at Delek US
In related news, CFO Mark Wayne Hobbs acquired 2,800 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was acquired at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the transaction, the chief financial officer now directly owns 49,138 shares in the company, valued at $673,190.60. This trade represents a 6.04 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have purchased a total of 5,055 shares of company stock worth $70,787 in the last 90 days. Corporate insiders own 1.80% of the company's stock.
Delek US Company Profile
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Featured Articles

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.